Researchers in Prof. Anson Lowe's laboratory have discovered a potential cancer therapy based on a naturally-occurring negative regulator of a protein with oncogenic effects in a wide range of adenocarcinomas. This regulator is AGR3 (anterior gradient homolog 3).